TY - JOUR
T1 - Chromosomal aberrations in tuberculosis patients before and after treatment with short-term chemotherapy
AU - Gopal Rao, V. V.N.
AU - Venkatarama Gupta, E. V.
AU - Thomas, I. M.
PY - 1991/1
Y1 - 1991/1
N2 - Cytogenetic effects of 4 common anti-tubercular drugs, isoniazid (H), streptomycin (S), rifampicin (R) and pyrazinamide (Z), in 3 different combinations (2 SHRZ, 2 HRZ and 2 H2R2Z2) were evaluated in the lymphocytes of tuberculosis patients undergoing chemotherapy, in order to estimate their mutagenic potential in combination. All 3 regimens showed an increased frequency of chromosomal aberrations after treatment compared to before treatment. These findings are of significance in the treatment of tuberculosis, as the drugs in question are observed to be mutagenic/clastogenic.
AB - Cytogenetic effects of 4 common anti-tubercular drugs, isoniazid (H), streptomycin (S), rifampicin (R) and pyrazinamide (Z), in 3 different combinations (2 SHRZ, 2 HRZ and 2 H2R2Z2) were evaluated in the lymphocytes of tuberculosis patients undergoing chemotherapy, in order to estimate their mutagenic potential in combination. All 3 regimens showed an increased frequency of chromosomal aberrations after treatment compared to before treatment. These findings are of significance in the treatment of tuberculosis, as the drugs in question are observed to be mutagenic/clastogenic.
KW - Cytogenetic effects
KW - Tuberculosis chemotherapy
UR - http://www.scopus.com/inward/record.url?scp=0026018588&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026018588&partnerID=8YFLogxK
U2 - 10.1016/0165-1218(91)90104-T
DO - 10.1016/0165-1218(91)90104-T
M3 - Article
C2 - 1988820
AN - SCOPUS:0026018588
SN - 0165-1218
VL - 259
SP - 13
EP - 19
JO - Mutation Research/Genetic Toxicology
JF - Mutation Research/Genetic Toxicology
IS - 1
ER -